Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: Long-term outcomes of a phase I-II trial. Radiol Oncol. 2022;56(2):216-227. Accessed September 23, 2026. https://www.radioloncol.com/index.php/ro/article/view/3744